Pali Research downgrades DR Horton Inc. (NYSE: DHI) from Buy to Neutral, citing valuation.

The firm notes, "Back in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE